This perspective demonstrates the potential of extracellular vesicles for delivering therapeutics and biomarkers in ischemic stroke, highlighting ongoing clinical trials.
Key Points
The research explores the role of extracellular vesicles in managing ischemic stroke and their potential as therapeutic agents.
Overview of current literature on extracellular vesicles and their applications in stroke management.
Discussion of synergistic effects with other therapeutic agents and their use as biomarkers.
Evaluation of ongoing clinical trials and challenges regarding clinical translation.
Extracellular vesicles can protect and deliver molecular cargo like proteins and DNA.
They show significant promise in mitigating ischemic stroke mechanisms such as neuroinflammation and apoptosis.
Clinical trials are exploring the efficacy of EV-based systems in therapeutic applications.